News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rohlen Douglas
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/28/2021 |
4
| Rohlen Douglas (Director) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Disposed/sold 21,447 options to buy
@ $41.42, valued at
$888.3k
Disposed/sold 4,526 restricted stock units
@ $0 |
|
| 08/10/2020 |
4
| Rohlen Douglas (Director) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 4,526 restricted stock units
@ $0
Granted 21,447 options to buy
@ $41.42, valued at
$888.3k
|
|
| 08/10/2020 |
3
| Rohlen Douglas (Director) has filed a Form 3 on Eidos Therapeutics, Inc. |
| 03/01/2018 |
4
| Rohlen Douglas (Director) has filed a Form 4 on ENTELLUS MEDICAL INC|
Txns:
| Disposed/sold 9,217 shares
@ $24, valued at
$221.2k
Disposed/sold 6,834 shares
@ $24, valued at
$164k
Disposed/sold 20,299 shares
@ $24, valued at
$487.2k
Disposed/sold 4,684 shares
@ $24, valued at
$112.4k
Disposed/sold 7,500 options to buy
@ $17.67, valued at
$132.5k
|
|
| 07/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|